1 Meningitis Vaccine Market Overview 1.1 Product Overview and Scope of Meningitis Vaccine 1.2 Meningitis Vaccine Segment by Type 1.2.1 Global Meningitis Vaccine Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Meningitis A+C 1.2.3 Meningitis ACWY135 1.2.4 Meningitis B 1.3 Meningitis Vaccine Segment by Application 1.3.1 Global Meningitis Vaccine Sales Comparison by Application: (2021-2027) 1.3.2 Medical Care 1.3.3 Hospital 1.4 Global Meningitis Vaccine Market Size Estimates and Forecasts 1.4.1 Global Meningitis Vaccine Revenue 2016-2027 1.4.2 Global Meningitis Vaccine Sales 2016-2027 1.4.3 Meningitis Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027 2 Meningitis Vaccine Market Competition by Manufacturers 2.1 Global Meningitis Vaccine Sales Market Share by Manufacturers (2016-2021) 2.2 Global Meningitis Vaccine Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Meningitis Vaccine Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Meningitis Vaccine Manufacturing Sites, Area Served, Product Type 2.5 Meningitis Vaccine Market Competitive Situation and Trends 2.5.1 Meningitis Vaccine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Meningitis Vaccine Players Market Share by Revenue 2.5.3 Global Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Meningitis Vaccine Retrospective Market Scenario by Region 3.1 Global Meningitis Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Meningitis Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Meningitis Vaccine Market Facts & Figures by Country 3.3.1 North America Meningitis Vaccine Sales by Country 3.3.2 North America Meningitis Vaccine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Meningitis Vaccine Market Facts & Figures by Country 3.4.1 Europe Meningitis Vaccine Sales by Country 3.4.2 Europe Meningitis Vaccine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Meningitis Vaccine Market Facts & Figures by Region 3.5.1 Asia Pacific Meningitis Vaccine Sales by Region 3.5.2 Asia Pacific Meningitis Vaccine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Meningitis Vaccine Market Facts & Figures by Country 3.6.1 Latin America Meningitis Vaccine Sales by Country 3.6.2 Latin America Meningitis Vaccine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Meningitis Vaccine Market Facts & Figures by Country 3.7.1 Middle East and Africa Meningitis Vaccine Sales by Country 3.7.2 Middle East and Africa Meningitis Vaccine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Meningitis Vaccine Historic Market Analysis by Type 4.1 Global Meningitis Vaccine Sales Market Share by Type (2016-2021) 4.2 Global Meningitis Vaccine Revenue Market Share by Type (2016-2021) 4.3 Global Meningitis Vaccine Price by Type (2016-2021) 5 Global Meningitis Vaccine Historic Market Analysis by Application 5.1 Global Meningitis Vaccine Sales Market Share by Application (2016-2021) 5.2 Global Meningitis Vaccine Revenue Market Share by Application (2016-2021) 5.3 Global Meningitis Vaccine Price by Application (2016-2021) 6 Key Companies Profiled 6.1 GlaxoSmithKline 6.1.1 GlaxoSmithKline Corporation Information 6.1.2 GlaxoSmithKline Description and Business Overview 6.1.3 GlaxoSmithKline Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.1.4 GlaxoSmithKline Meningitis Vaccine Product Portfolio 6.1.5 GlaxoSmithKline Recent Developments/Updates 6.2 Baxter International 6.2.1 Baxter International Corporation Information 6.2.2 Baxter International Description and Business Overview 6.2.3 Baxter International Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Baxter International Meningitis Vaccine Product Portfolio 6.2.5 Baxter International Recent Developments/Updates 6.3 Sanofi Pasteur 6.3.1 Sanofi Pasteur Corporation Information 6.3.2 Sanofi Pasteur Description and Business Overview 6.3.3 Sanofi Pasteur Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Sanofi Pasteur Meningitis Vaccine Product Portfolio 6.3.5 Sanofi Pasteur Recent Developments/Updates 6.4 Merck 6.4.1 Merck Corporation Information 6.4.2 Merck Description and Business Overview 6.4.3 Merck Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Merck Meningitis Vaccine Product Portfolio 6.4.5 Merck Recent Developments/Updates 6.5 Novartis 6.5.1 Novartis Corporation Information 6.5.2 Novartis Description and Business Overview 6.5.3 Novartis Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Novartis Meningitis Vaccine Product Portfolio 6.5.5 Novartis Recent Developments/Updates 6.6 Pfizer 6.6.1 Pfizer Corporation Information 6.6.2 Pfizer Description and Business Overview 6.6.3 Pfizer Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Pfizer Meningitis Vaccine Product Portfolio 6.6.5 Pfizer Recent Developments/Updates 6.7 Hualan 6.6.1 Hualan Corporation Information 6.6.2 Hualan Description and Business Overview 6.6.3 Hualan Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Hualan Meningitis Vaccine Product Portfolio 6.7.5 Hualan Recent Developments/Updates 6.8 Zhejiang Tianyuan 6.8.1 Zhejiang Tianyuan Corporation Information 6.8.2 Zhejiang Tianyuan Description and Business Overview 6.8.3 Zhejiang Tianyuan Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Zhejiang Tianyuan Meningitis Vaccine Product Portfolio 6.8.5 Zhejiang Tianyuan Recent Developments/Updates 6.9 Beijing Tiantan Biological 6.9.1 Beijing Tiantan Biological Corporation Information 6.9.2 Beijing Tiantan Biological Description and Business Overview 6.9.3 Beijing Tiantan Biological Meningitis Vaccine Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Beijing Tiantan Biological Meningitis Vaccine Product Portfolio 6.9.5 Beijing Tiantan Biological Recent Developments/Updates 7 Meningitis Vaccine Manufacturing Cost Analysis 7.1 Meningitis Vaccine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Meningitis Vaccine 7.4 Meningitis Vaccine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Meningitis Vaccine Distributors List 8.3 Meningitis Vaccine Customers 9 Meningitis Vaccine Market Dynamics 9.1 Meningitis Vaccine Industry Trends 9.2 Meningitis Vaccine Growth Drivers 9.3 Meningitis Vaccine Market Challenges 9.4 Meningitis Vaccine Market Restraints 10 Global Market Forecast 10.1 Meningitis Vaccine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Meningitis Vaccine by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Meningitis Vaccine by Type (2022-2027) 10.2 Meningitis Vaccine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Meningitis Vaccine by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Meningitis Vaccine by Application (2022-2027) 10.3 Meningitis Vaccine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Meningitis Vaccine by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Meningitis Vaccine by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Meningitis Vaccine Sales (K MT) Growth Rate Comparison by Type (2021-2027) Table 2. Global Meningitis Vaccine Sales (K MT) Comparison by Application (2021-2027) Table 3. Global Meningitis Vaccine Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Meningitis Vaccine Covered in This Study Table 5. Global Meningitis Vaccine Sales (K MT) of Key Manufacturers (2016-2021) Table 6. Global Meningitis Vaccine Sales Market Share by Manufacturers (2016-2021) Table 7. Global Meningitis Vaccine Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Meningitis Vaccine Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Meningitis Vaccine Average Price (USD/MT) of Key Manufacturers (2016-2021) Table 10. Manufacturers Meningitis Vaccine Manufacturing Sites and Area Served Table 11. Manufacturers Meningitis Vaccine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Meningitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Meningitis Vaccine as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Meningitis Vaccine Sales by Region (2016-2021) & (K MT) Table 16. Global Meningitis Vaccine Sales Market Share by Region (2016-2021) Table 17. Global Meningitis Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Meningitis Vaccine Sales by Country (2016-2021) & (K MT) Table 19. North America Meningitis Vaccine Sales Market Share by Country (2016-2021) Table 20. North America Meningitis Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Meningitis Vaccine Revenue Market Share by Country (2016-2021) Table 22. Europe Meningitis Vaccine Sales by Country (2016-2021) & (K MT) Table 23. Europe Meningitis Vaccine Sales Market Share by Country (2016-2021) Table 24. Europe Meningitis Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Meningitis Vaccine Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Meningitis Vaccine Sales by Region (2016-2021) & (K MT) Table 27. Asia Pacific Meningitis Vaccine Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Meningitis Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Meningitis Vaccine Revenue Market Share by Region (2016-2021) Table 30. Latin America Meningitis Vaccine Sales by Country (2016-2021) & (K MT) Table 31. Latin America Meningitis Vaccine Sales Market Share by Country (2016-2021) Table 32. Latin America Meningitis Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Meningitis Vaccine Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Meningitis Vaccine Sales by Country (2016-2021) & (K MT) Table 35. Middle East and Africa Meningitis Vaccine Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Meningitis Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Meningitis Vaccine Revenue Market Share by Country (2016-2021) Table 38. Global Meningitis Vaccine Sales (K MT) by Type (2016-2021) Table 39. Global Meningitis Vaccine Sales Market Share by Type (2016-2021) Table 40. Global Meningitis Vaccine Revenue (Million US$) by Type (2016-2021) Table 41. Global Meningitis Vaccine Revenue Share by Type (2016-2021) Table 42. Global Meningitis Vaccine Price (USD/MT) by Type (2016-2021) Table 43. Global Meningitis Vaccine Sales (K MT) by Application (2016-2021) Table 44. Global Meningitis Vaccine Sales Market Share by Application (2016-2021) Table 45. Global Meningitis Vaccine Revenue (Million US$) by Application (2016-2021) Table 46. Global Meningitis Vaccine Revenue Share by Application (2016-2021) Table 47. Global Meningitis Vaccine Price (USD/MT) by Application (2016-2021) Table 48. GlaxoSmithKline Corporation Information Table 49. GlaxoSmithKline Description and Business Overview Table 50. GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 51. GlaxoSmithKline Meningitis Vaccine Product Table 52. GlaxoSmithKline Recent Developments/Updates Table 53. Baxter International Corporation Information Table 54. Baxter International Description and Business Overview Table 55. Baxter International Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 56. Baxter International Meningitis Vaccine Product Table 57. Baxter International Recent Developments/Updates Table 58. Sanofi Pasteur Corporation Information Table 59. Sanofi Pasteur Description and Business Overview Table 60. Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 61. Sanofi Pasteur Meningitis Vaccine Product Table 62. Sanofi Pasteur Recent Developments/Updates Table 63. Merck Corporation Information Table 64. Merck Description and Business Overview Table 65. Merck Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 66. Merck Meningitis Vaccine Product Table 67. Merck Recent Developments/Updates Table 68. Novartis Corporation Information Table 69. Novartis Description and Business Overview Table 70. Novartis Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 71. Novartis Meningitis Vaccine Product Table 72. Novartis Recent Developments/Updates Table 73. Pfizer Corporation Information Table 74. Pfizer Description and Business Overview Table 75. Pfizer Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 76. Pfizer Meningitis Vaccine Product Table 77. Pfizer Recent Developments/Updates Table 78. Hualan Corporation Information Table 79. Hualan Description and Business Overview Table 80. Hualan Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 81. Hualan Meningitis Vaccine Product Table 82. Hualan Recent Developments/Updates Table 83. Zhejiang Tianyuan Corporation Information Table 84. Zhejiang Tianyuan Description and Business Overview Table 85. Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 86. Zhejiang Tianyuan Meningitis Vaccine Product Table 87. Zhejiang Tianyuan Recent Developments/Updates Table 88. Beijing Tiantan Biological Corporation Information Table 89. Beijing Tiantan Biological Description and Business Overview Table 90. Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2021) Table 91. Beijing Tiantan Biological Meningitis Vaccine Product Table 92. Beijing Tiantan Biological Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Meningitis Vaccine Distributors List Table 96. Meningitis Vaccine Customers List Table 97. Meningitis Vaccine Market Trends Table 98. Meningitis Vaccine Growth Drivers Table 99. Meningitis Vaccine Market Challenges Table 100. Meningitis Vaccine Market Restraints Table 101. Global Meningitis Vaccine Sales Forecast by Type (2022-2027) & (K MT) Table 102. Global Meningitis Vaccine Sales Market Share Forecast by Type (2022-2027) Table 103. Global Meningitis Vaccine Revenue Forecast by Type (2022-2027) & (US$ Million) Table 104. Global Meningitis Vaccine Revenue Market Share Forecast by Type (2022-2027) Table 105. Global Meningitis Vaccine Sales Forecast by Application (2022-2027) & (K MT) Table 106. Global Meningitis Vaccine Sales Market Share Forecast by Application (2022-2027) Table 107. Global Meningitis Vaccine Revenue Forecast by Application (2022-2027) & (US$ Million) Table 108. Global Meningitis Vaccine Revenue Market Share Forecast by Application (2022-2027) Table 109. Global Meningitis Vaccine Sales Forecast by Region (2022-2027) & (K MT) Table 110. Global Meningitis Vaccine Sales Market Share Forecast by Region (2022-2027) Table 111. Global Meningitis Vaccine Revenue Forecast by Region (2022-2027) & (US$ Million) Table 112. Global Meningitis Vaccine Revenue Market Share Forecast by Region (2022-2027) Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Meningitis Vaccine Figure 2. Global Meningitis Vaccine Market Share by Type in 2020 & 2027 Figure 3. Meningitis A+C Product Picture Figure 4. Meningitis ACWY135 Product Picture Figure 5. Meningitis B Product Picture Figure 6. Global Meningitis Vaccine Market Share by Application in 2020 & 2027 Figure 7. Medical Care Figure 8. Hospital Figure 9. Global Meningitis Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Meningitis Vaccine Market Size 2016-2027 (US$ Million) Figure 11. Global Meningitis Vaccine Sales 2016-2027 (K MT) Figure 12. Global Meningitis Vaccine Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Meningitis Vaccine Sales Share by Manufacturers in 2020 Figure 14. Global Meningitis Vaccine Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Meningitis Vaccine Players: Market Share by Revenue in 2020 Figure 16. Meningitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Meningitis Vaccine Sales Market Share by Region (2016-2021) Figure 18. Global Meningitis Vaccine Sales Market Share by Region in 2020 Figure 19. Global Meningitis Vaccine Revenue Market Share by Region (2016-2021) Figure 20. Global Meningitis Vaccine Revenue Market Share by Region in 2020 Figure 21. U.S. Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. UAE Meningitis Vaccine Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Meningitis Vaccine by Type (2016-2021) Figure 46. Sales Market Share of Meningitis Vaccine by Application (2016-2021) Figure 47. Sales Market Share of Meningitis Vaccine by Application in 2020 Figure 48. Revenue Share of Meningitis Vaccine by Application (2016-2021) Figure 49. Revenue Share of Meningitis Vaccine by Application in 2020 Figure 50. Manufacturing Cost Structure of Meningitis Vaccine Figure 51. Manufacturing Process Analysis of Meningitis Vaccine Figure 52. Meningitis Vaccine Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

GlaxoSmithKline Baxter International Sanofi Pasteur Merck Novartis Pfizer Hualan Zhejiang Tianyuan Beijing Tiantan Biological